Debbie Milliken presents at JLABS @ Toronto on June 15th with other market access experts.
“Introduction to Market Access” workshop for Canadian healthcare startups.
Topics include:
The Canadian Association of Healthcare Reimbursement (CAHR) hosts “Biologics – What does the Future Hold?” on June 11, 2014 in Toronto.
Debbie Milliken, Managing Director, MILLREED Enterprises Ltd presents on the Pan-Canadian Pricing Alliance (PCPA) and implications for biologic drugs.
The Enbridge Ride to Conquer Cancer, benefiting the Princess Margaret Cancer Centre took place on June 7th and 8th, 2014. This year’s ride raised over $20 million and included 5,212 riders. Debbie Milliken, Managing Director MILLREED Enterprises Ltd took part in the event. Congratulations to all riders and crew on this fabulous accomplishment and supporting the fundraising efforts of one of the world’s five top cancer research institutions!
Consider participating in the Ontario Health Study. The Study is one of the largest long-term health studies ever attempted in North America and already nearly 225,000 Ontarians have taken the online survey. The information obtained through the survey will help scientists understand the risk factors and causes of chronic diseases and spur the creation of new prevention strategies and treatments.
Learn more and spread the word!
The Pan-Canadian Oncology Drug Review (pCODR) and the Canadian Partnership Against Cancer have developed a useful tutorial addressing questions on how cancer drug funding decisions are made in Canada.
Focus on men’s health in “Movember” and learn more about education and awareness efforts to raise the profile of cancers effecting men and mental health.
